Literature DB >> 26062981

Efficient Gene Editing in Pluripotent Stem Cells by Bacterial Injection of Transcription Activator-Like Effector Nuclease Proteins.

Jingyue Jia1, Fang Bai1, Yongxin Jin1, Katherine E Santostefano1, Un-Hwan Ha1, Donghai Wu1, Weihui Wu2, Naohiro Terada2, Shouguang Jin2.   

Abstract

The type III secretion system (T3SS) of Pseudomonas aeruginosa is a powerful tool for direct protein delivery into mammalian cells and has successfully been used to deliver various exogenous proteins into mammalian cells. In the present study, transcription activator-like effector nuclease (TALEN) proteins have been efficiently delivered using the P. aeruginosa T3SS into mouse embryonic stem cells (mESCs), human ESCs (hESCs), and human induced pluripotent stem cells (hiPSCs) for genome editing. This bacterial delivery system offers an alternative method of TALEN delivery that is highly efficient in cleavage of the chromosomal target and presumably safer by avoiding plasmid DNA introduction. We combined the method of bacterial T3SS-mediated TALEN protein injection and transfection of an oligonucleotide template to effectively generate precise genetic modifications in the stem cells. Initially, we efficiently edited a single-base in the gfp gene of a mESC line to silence green fluorescent protein (GFP) production. The resulting GFP-negative mESC was cloned from a single cell and subsequently mutated back to a GFP-positive mESC line. Using the same approach, the gfp gene was also effectively knocked out in hESCs. In addition, a defined single-base edition was effectively introduced into the X-chromosome-linked HPRT1 gene in hiPSCs, generating an in vitro model of Lesch-Nyhan syndrome. T3SS-mediated TALEN protein delivery provides a highly efficient alternative for introducing precise gene editing within pluripotent stem cells for the purpose of disease genotype-phenotype relationship studies and cellular replacement therapies. ©AlphaMed Press.

Entities:  

Keywords:  Embryonic stem cell; Genome editing; Transcription activator-like effector nuclease; Type III secretion system; iPS cell

Mesh:

Substances:

Year:  2015        PMID: 26062981      PMCID: PMC4511150          DOI: 10.5966/sctm.2015-0030

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  36 in total

1.  Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

Authors:  F Ann Ran; Patrick D Hsu; Chie-Yu Lin; Jonathan S Gootenberg; Silvana Konermann; Alexandro E Trevino; David A Scott; Azusa Inoue; Shogo Matoba; Yi Zhang; Feng Zhang
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

Review 2.  Progress and prospects: targeted gene alteration (TGA).

Authors:  H Parekh-Olmedo; E B Kmiec
Journal:  Gene Ther       Date:  2007-11-01       Impact factor: 5.250

3.  Knockout rats generated by embryo microinjection of TALENs.

Authors:  Laurent Tesson; Claire Usal; Séverine Ménoret; Elo Leung; Brett J Niles; Séverine Remy; Yolanda Santiago; Anna I Vincent; Xiangdong Meng; Lei Zhang; Philip D Gregory; Ignacio Anegon; Gregory J Cost
Journal:  Nat Biotechnol       Date:  2011-08-05       Impact factor: 54.908

4.  Direct reprogramming of fibroblasts to myocytes via bacterial injection of MyoD protein.

Authors:  Candace Bichsel; Dennis Neeld; Takashi Hamazaki; Lung-Ji Chang; Li-Jun Yang; Naohiro Terada; Shouguang Jin
Journal:  Cell Reprogram       Date:  2013-02-25       Impact factor: 1.987

Review 5.  TALEN-mediated genome editing: prospects and perspectives.

Authors:  David A Wright; Ting Li; Bing Yang; Martin H Spalding
Journal:  Biochem J       Date:  2014-08-15       Impact factor: 3.857

Review 6.  Pseudomonas aeruginosa: new insights into pathogenesis and host defenses.

Authors:  Shaan L Gellatly; Robert E W Hancock
Journal:  Pathog Dis       Date:  2013-03-15       Impact factor: 3.166

Review 7.  ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering.

Authors:  Thomas Gaj; Charles A Gersbach; Carlos F Barbas
Journal:  Trends Biotechnol       Date:  2013-05-09       Impact factor: 19.536

8.  Isolation of single-base genome-edited human iPS cells without antibiotic selection.

Authors:  Yuichiro Miyaoka; Amanda H Chan; Luke M Judge; Jennie Yoo; Miller Huang; Trieu D Nguyen; Paweena P Lizarraga; Po-Lin So; Bruce R Conklin
Journal:  Nat Methods       Date:  2014-02-09       Impact factor: 28.547

9.  The position of DNA cleavage by TALENs and cell synchronization influences the frequency of gene editing directed by single-stranded oligonucleotides.

Authors:  Natalia Rivera-Torres; Bryan Strouse; Pawel Bialk; Rohina A Niamat; Eric B Kmiec
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

10.  Improving CRISPR-Cas nuclease specificity using truncated guide RNAs.

Authors:  Yanfang Fu; Jeffry D Sander; Deepak Reyon; Vincent M Cascio; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-01-26       Impact factor: 54.908

View more
  6 in total

Review 1.  Bacterial type III secretion system as a protein delivery tool for a broad range of biomedical applications.

Authors:  Fang Bai; Zhenpeng Li; Akihiro Umezawa; Naohiro Terada; Shouguang Jin
Journal:  Biotechnol Adv       Date:  2018-02-02       Impact factor: 14.227

Review 2.  Rationale redesign of type III secretion systems: toward the development of non-pathogenic E. coli for in vivo delivery of therapeutic payloads.

Authors:  Coral González-Prieto; Cammie F Lesser
Journal:  Curr Opin Microbiol       Date:  2017-11-12       Impact factor: 7.934

3.  Enhanced differentiation of human pluripotent stem cells into cardiomyocytes by bacteria-mediated transcription factors delivery.

Authors:  Yongxin Jin; Ying Liu; Zhenpeng Li; Katherine Santostefano; Jing Shi; Xinwen Zhang; Donghai Wu; Zhihui Cheng; Weihui Wu; Naohiro Terada; Shouguang Jin; Fang Bai
Journal:  PLoS One       Date:  2018-03-26       Impact factor: 3.240

Review 4.  Intracellular delivery of biologic therapeutics by bacterial secretion systems.

Authors:  Barnabas James Walker; Guy-Bart V Stan; Karen Marie Polizzi
Journal:  Expert Rev Mol Med       Date:  2017-04-06       Impact factor: 5.600

5.  Salmonella-based platform for efficient delivery of functional binding proteins to the cytosol.

Authors:  Antoine Chabloz; Jonas V Schaefer; Ivona Kozieradzki; Shane J F Cronin; Daniel Strebinger; Francesca Macaluso; Jiri Wald; Terence H Rabbitts; Andreas Plückthun; Thomas C Marlovits; Josef M Penninger
Journal:  Commun Biol       Date:  2020-07-03

Review 6.  Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer.

Authors:  Pourya Sarvari; Pouya Sarvari; Ivonne Ramírez-Díaz; Frouzandeh Mahjoubi; Karla Rubio
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.